The EU General Court confirms the decision of the EU Commission concerning its first pharma pay-for-delay case (Lundbeck)

Antitrust: Commission welcomes General Court judgments upholding its Lundbeck decision in first pharma pay-for-delay case Today the General Court upheld the Commission's Lundbeck decision and ruled for the first time that pharma pay-for-delay agreements breach EU antitrust rules. In such agreements an original pharmaceutical manufacturer pays generics producers to stay out of the market. The European Commission welcomes today's judgments by the General Court fully upholding its Lundbeck decision (cases T-472/13, T-460/13, T-467/13, T-469/13, T-470/13,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

European Commission, The EU General Court confirms the decision of the EU Commission concerning its first pharma pay-for-delay case (Lundbeck), 8 September 2016, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 81274

Visites 168

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues